Gensenoside Rg3 Inhibits Hypoxia-induced VEGF Expression in Human Cancer Cells

Abstract

Rg3 targets hypoxia-induced multiple signaling pathways to down-regulate VEGF expression in cancer cells. These actions may contribute to the overall efficacy of Rg3 against tumor angiogenesis and growth.